Reduce the cost of blood culture contamination
Better collections help protect your bottom line.
The financial cost of false positive blood cultures
For an average hospital, 1/3 of positive blood cultures may be contaminated, driving more than $1M in unnecessary annual treatment costs.
Nationally, false positive blood cultures can contribute to billions in avoidable healthcare spending each year.
Many contamination-related outcomes are non-reimbursable, creating direct margin impact for hospitals.
Failure to meet CMS infection prevention and antibiotic stewardship requirements may contribute to reimbursement risk and penalties.
The Kurin Experience
Better Cultures, Better Outcomes
Save Lives
Reducing contamination may help improve diagnostic accuracy and prevent unnecessary treatment, thereby lowering patient risk.
Save Resources
Responding to a false positive result may consume limited hospital resources and inpatient capacity.
.png)